Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer

Objective:In this study, we aimed to evaluate the prognostic value of axillary lymph node ratio (LNR) for disease-free survival (DFS) in node positive breast cancer (BC) patients with long term follow-up.Materials and Methods:A total of 179 stage II to III female BC patients, who were followed betwe...

Full description

Bibliographic Details
Main Authors: Ayşegül Sakin, Mehmet Naci Aldemir
Format: Article
Language:English
Published: Galenos Publishing House 2020-10-01
Series:European Journal of Breast Health
Subjects:
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/lymph-node-ratio-predicts-long-term-survival-in-ly/41892
_version_ 1797916151622139904
author Ayşegül Sakin
Mehmet Naci Aldemir
author_facet Ayşegül Sakin
Mehmet Naci Aldemir
author_sort Ayşegül Sakin
collection DOAJ
description Objective:In this study, we aimed to evaluate the prognostic value of axillary lymph node ratio (LNR) for disease-free survival (DFS) in node positive breast cancer (BC) patients with long term follow-up.Materials and Methods:A total of 179 stage II to III female BC patients, who were followed between December 2001 and January 2019 at the department of medical oncology, were included in this study. Patients were classified into 3 groups based on the LNR as follows; LNR<0.21, LNR=0.21-0.65, and LNR>0.65. SPSS 22 for windows was used for statistical analysis.Results:The median age was 49 (range, 24-83) years. The numbers of patients with stage II and stage III disease were 81 (45.3%) and 98 (54.7%), respectively. The median number of lymph node (LN) resected and positive LN were 15 (range, 3-48) and 3 (range, 1-29), respectively. There were 90 patients (50.3%) with LNR <0.21, 62 (34.6%) with LNR=0.21-0.65, and 27 (15.1%) with LNR >0.65. The median disease-free survival (DFS) was not reached in patients with LNR <0.21, 81 months in patients with LNR=0.21-0.65, and 43 months in patients with LNR>0.65 (p<0.001). Overall survival (OS) was found to be significantly related to LNR (p=0.042). In patients with LNR<0.21 and LNR=0.21-0.65, the median OS was not reached. In patients with LNR >0.65, the median OS was 101 months. In multivariate analysis, LNR=0.21-0.65 (Hazard ratio [HR], 6.99), LNR>0.65 (HR, 28.99), and HER-2 negativity (HR, 4.64) were the factors associated with DFS (p<0.05).Conclusion:LNR is a more useful prognostic factor than the pathological lymph node staging for predicting survival in patients with nod-positive BC.
first_indexed 2024-04-10T12:52:39Z
format Article
id doaj.art-52a7ba48b3274665ae071f94bca2b97e
institution Directory Open Access Journal
issn 2587-0831
language English
last_indexed 2024-04-10T12:52:39Z
publishDate 2020-10-01
publisher Galenos Publishing House
record_format Article
series European Journal of Breast Health
spelling doaj.art-52a7ba48b3274665ae071f94bca2b97e2023-02-15T16:13:39ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312020-10-0116427027510.5152/ejbh.2020.580913049054Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast CancerAyşegül Sakin0Mehmet Naci Aldemir1 Department of Internal medicine, University of Health Sciences, Van Research and Training Hospital, Van, Turkey Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Van, Turkey Objective:In this study, we aimed to evaluate the prognostic value of axillary lymph node ratio (LNR) for disease-free survival (DFS) in node positive breast cancer (BC) patients with long term follow-up.Materials and Methods:A total of 179 stage II to III female BC patients, who were followed between December 2001 and January 2019 at the department of medical oncology, were included in this study. Patients were classified into 3 groups based on the LNR as follows; LNR<0.21, LNR=0.21-0.65, and LNR>0.65. SPSS 22 for windows was used for statistical analysis.Results:The median age was 49 (range, 24-83) years. The numbers of patients with stage II and stage III disease were 81 (45.3%) and 98 (54.7%), respectively. The median number of lymph node (LN) resected and positive LN were 15 (range, 3-48) and 3 (range, 1-29), respectively. There were 90 patients (50.3%) with LNR <0.21, 62 (34.6%) with LNR=0.21-0.65, and 27 (15.1%) with LNR >0.65. The median disease-free survival (DFS) was not reached in patients with LNR <0.21, 81 months in patients with LNR=0.21-0.65, and 43 months in patients with LNR>0.65 (p<0.001). Overall survival (OS) was found to be significantly related to LNR (p=0.042). In patients with LNR<0.21 and LNR=0.21-0.65, the median OS was not reached. In patients with LNR >0.65, the median OS was 101 months. In multivariate analysis, LNR=0.21-0.65 (Hazard ratio [HR], 6.99), LNR>0.65 (HR, 28.99), and HER-2 negativity (HR, 4.64) were the factors associated with DFS (p<0.05).Conclusion:LNR is a more useful prognostic factor than the pathological lymph node staging for predicting survival in patients with nod-positive BC. http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/lymph-node-ratio-predicts-long-term-survival-in-ly/41892 breast cancerlymph node ratiosurvival
spellingShingle Ayşegül Sakin
Mehmet Naci Aldemir
Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
European Journal of Breast Health
breast cancer
lymph node ratio
survival
title Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
title_full Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
title_fullStr Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
title_full_unstemmed Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
title_short Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
title_sort lymph node ratio predicts long term survival in lymph node positive breast cancer
topic breast cancer
lymph node ratio
survival
url http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/lymph-node-ratio-predicts-long-term-survival-in-ly/41892
work_keys_str_mv AT aysegulsakin lymphnoderatiopredictslongtermsurvivalinlymphnodepositivebreastcancer
AT mehmetnacialdemir lymphnoderatiopredictslongtermsurvivalinlymphnodepositivebreastcancer